1.
Gancitano G, Ravasio R, Cattelino L, et al. Clinical Impact of two Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer. Farmeconomia. Health Economics and Therapeutic Pathways. 2020;21(1). https://doi.org/10.7175/fe.v21i1.1450